Skip to content

PERSPECTIVE THERAPEUTICS, INC.: 10-K filed 2013-09-30

What PERSPECTIVE THERAPEUTICS, INC. reported in its annual report filed 2013-09-30 (fiscal FY 2013): 35 published measures, 75 facts as tagged in accession 0001144204-13-053136.

This filing

Form
10-K (annual report)
Filed
2013-09-30
Fiscal period
fiscal FY 2013
Accession
0001144204-13-053136 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PERSPECTIVE THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-06-307,055,356USD
At 2012-06-307,505,482USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-06-301,689,110USD
At 2012-06-301,687,290USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-06-305,366,246USD
At 2012-06-305,818,192USD
At 2011-06-306,452,516USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-06-302,899,927USD
At 2012-06-302,672,711USD
At 2011-06-302,112,254USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2013-06-30-3,856,596USD365
2011-07-01 to 2012-06-30-3,488,905USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-07-01 to 2013-06-30-3,056,267USD365
2011-07-01 to 2012-06-30-2,447,775USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-07-01 to 2013-06-306,576USD365
2011-07-01 to 2012-06-3055,057USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-07-01 to 2013-06-303,296,299USD365
2011-07-01 to 2012-06-303,103,747USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-07-01 to 2013-06-30-12,816USD365
2011-07-01 to 2012-06-30-95,515USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-06-30-52,091,334USD
At 2012-06-30-48,234,738USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-06-301,684,282USD
At 2012-06-302,416,853USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-07-01 to 2013-06-30108,351USD365
2011-07-01 to 2012-06-30173,323USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2013-06-30-4,067,253USD365
2011-07-01 to 2012-06-30-3,597,970USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-06-304,443,660USD
At 2012-06-304,136,153USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-06-30792,868USD
At 2012-06-30648,992USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-06-30215,176USD
At 2012-06-30203,256USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-06-30923,780USD
At 2012-06-30865,056USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2013-06-304,217,429USD365
2011-07-01 to 2012-06-304,301,174USD366

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-06-30405,571USD
At 2012-06-30444,345USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-07-01 to 2013-06-30150,176USD365
2011-07-01 to 2012-06-30703,204USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-07-01 to 2013-06-30627,107USD365
2011-07-01 to 2012-06-30780,579USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-06-3034,618,517shares
At 2012-06-3030,950,108shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-06-3057,431,293USD
At 2012-06-3054,030,311USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-06-307,607,424USD
At 2012-06-307,600,848USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-06-305,923,142USD
At 2012-06-305,183,995USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-06-30276,507USD
At 2012-06-30301,691USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-06-30202,880USD
At 2012-06-30144,116USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-07-01 to 2013-06-30-3,867,228USD365
2011-07-01 to 2012-06-30-3,499,537USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2013-06-302,294,173USD365
2011-07-01 to 2012-06-302,355,015USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-07-01 to 2013-06-30739,147USD365
2011-07-01 to 2012-06-30847,115USD366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-07-01 to 2013-06-3019,581USD365
2011-07-01 to 2012-06-3015,731USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-07-01 to 2013-06-30210,657USD365
2011-07-01 to 2012-06-30109,065USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-07-01 to 2013-06-303,291,977USD365
2012-07-12 to 2012-07-133,291,977USD2
2011-07-01 to 2012-06-302,274,486USD366
2011-12-06 to 2011-12-07261,123USD2
2011-10-18 to 2011-10-192,013,363USD2

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-07-01 to 2013-06-3053,718USD365
2011-07-01 to 2012-06-3065,958USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-07-01 to 2013-06-30-38,774USD365
2011-07-01 to 2012-06-30164,254USD366

Inspect the source

Entity
PERSPECTIVE THERAPEUTICS, INC. / CIK 0000728387
Captured
2026-09-19T15:00:29.793Z
SEC response SHA-256
80792777921b49454c9d29f110283a1024ec5ce2a3749610d4c1319da49650fe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000728387.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))